This instrument has been designed to be used with Olympus endoscopes for Endoscopic Pancreatic Drainage. The Drainage Tube is not intended to be permanently implanted in the patient. The Drainage Tube is intended for short-term implantation. The Drainage Tube is also available as a kit, which includes accessories to aid in the placement of the Drainage Tube.

Device Description

Pancreatic Drainage Tube has been designed to be used with Olympus endoscopes for Endoscopic Pancreatic Drainage. The instrument consists of the Drainage Tube, and Insertion Kit and Guidewire. The Drainage Tube is not intended to be permanently implanted in the patient. The drainage Tube is intended for short-term implantation.

AI/ML Overview

This looks like a 510(k) premarket notification for a medical device called a "Pancreatic Drainage Tube." This type of document is a submission to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device, rather than a clinical study report with detailed performance metrics.

Therefore, the requested information regarding acceptance criteria, study design, sample sizes, expert ground truth, adjudication methods, MRMC studies, and standalone performance for an AI/CAD-like device is not applicable to this document.

Here's why and what information can be extracted:

No AI, CAD, or similar device: The Pancreatic Drainage Tube is a physical medical instrument (a stent for drainage), not an artificial intelligence algorithm or computer-aided detection system.
Substantial Equivalence: The primary goal of a 510(k) for this type of device is to show that it's as safe and effective as a previously cleared device. This typically involves comparisons of materials, design, intended use, and sometimes non-clinical (bench) testing, but not usually extensive clinical trials with performance metrics and ground truth establishment in the way an AI diagnostic device would.

Information Extracted from the Document (as relevant):

While I cannot provide the specific requested table and study details, I can tell you what this document does communicate about its clearance:

Acceptance Criteria/Performance (Implied): The acceptance criterion for a 510(k) is "substantial equivalence" to a predicate device in terms of safety and effectiveness. The reported "performance" is that the device "does not add any significant changes in the intended use, method of operation, material, or design that could affect the safety or effectiveness" when compared to the predicate device.
Study Type: This is a premarket notification (510(k)) based on a comparison to predicate devices, not a clinical effectiveness study in the sense of an AI/CAD device.
Ground Truth: For a physical device like this, "ground truth" relates to its physical properties, biocompatibility, and mechanical performance. The document states "Conclusions drawn from Non-clinical Tests" implying bench testing or material analyses were done, but no specific metrics are provided here.
Training Set/Test Set/Experts/Adjudication/MRMC/Standalone Performance: These concepts are entirely irrelevant to a 510(k) for a physical medical instrument like a pancreatic drainage tube. There's no AI algorithm to train or test, no diagnostic interpretation to be adjudicated by experts, and no human-in-the-loop performance to measure.

Summary of Relevant Information from the Provided Text:

Device Name: Pancreatic Drainage Tube
Intended Use: Used with Olympus endoscopes for Endoscopic Pancreatic Drainage. Not intended for permanent implantation; intended for short-term implantation.
Predicate Devices: Olympus PBD Stents #K933200 and Zimmon Endoscopic Pancreatic Stent (K900923 Wilson-Cook Medical, Inc.)
Basis for Clearance: Substantial equivalence to predicate devices, indicating no significant changes in intended use, method of operation, material, or design that could affect safety or effectiveness.
Testing: Non-clinical tests were performed, but specific details or quantitative results are not provided in this summary. The summary only states that these tests support the conclusion of substantial equivalence.

Summary

{0}------------------------------------------------

APR 1 6 2003

SMDA 510(k) SUMMARY

A. Submitter's Name, Address, Phone and Fax Numbers

1. Manufacturer of the subject device

Name & Address of manufacturer:

Registration No .: Address, Phone and Fax Numbers: of R&D Department, Endoscope Division

Olympus Optical Co., Ltd. 2-3-1 Shinjyuku Monolis Nishi-Shinjuku, Shinjyuku-ku Tokyo, Tokyo 163-0914 Japan 8010047 2951 Ishikawa-Cho, Hachioji-shi, Tokyo 192-8507 Japan TEL 426-42-5177 . FAX 426-46-5613

B. Name of Contact Person

Name: Address, Phone and Fax Numbers:

Ms. Laura Storms-Tyler Olympus America Inc. Two Corporate Center Drive Melville, New York 11747-3157 TEL: (631) 844-5688 FAX: (631) 844-5554

C. Device Name, Common Name, Classification Name and Predicate Devices

Trade Name:	Pancreatic Drainage Tube
Common Name:	Stent
Classification:	21CFR #876.5010 Biliary catheter and accessories21CFR #876.1500 Endoscope and accessories
Predicate Device:	Olympus PBD Stents #K933200Zimmon Endoscopic Pancreatic Stent

Zimmon Endoscopic Pancreatic Stent (K900923 Wilson-Cook Medical, Inc.)

{1}------------------------------------------------

D. Description of the Device(s)

E. Intended Use of the Device(s)

Pancreatic Drainage Tube has been designed to be used with Olympus endoscopes for Endoscopic Pancreatic Drainage. The Drainage Tube is not intended to be permanently implanted in the patient. The Drainage Tube is intended for short-term implantation.

F. Summary including Conclusions drawn from Non-clinical Tests

When compared to the predicate device, the subject device does not add any significant changes in the intended use, method of operation, material, or design that could affect the safety or effectiveness.

{2}------------------------------------------------

APR 1 6 2003

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ms. Tina Steffanie-Oak Senior R.A. Analyst Olympus America Inc. 2 Corporate Center Drive MELVILLE NY 11747-3157

Re: K021672

Trade/Device Name: Pancreatic Drainage Tube Regulation Number: 21 CFR $876.5010 Regulation Name: Biliary catheter and accessories Regulatory Class: II Product Code: 78 FGE Dated: March 7, 2003 Received: March 11, 2003

Dear Ms. Steffanie-Oak:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. However, you are responsible to determine that the medical devices you use as components in the kit have either been determined as substantially equivalent under the premarket notification process (Section 510(k) of the act), or were legally on the market prior to May 28, 1976, the enactment date of the Medical Device Amendments. Please note: If you purchase your device components in bulk (i.e., unfinished) and further process (e.g., sterilize) you must submit a new 510(k) before including these components in your kit. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 -- Ms. Tina Steffanie-Oak

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration (21 CFR Part 807); listing (21 CFR Part 807), labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on the labeling regulation, please contact the Office of Compliance at (301) 594-4616. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll free number (800) 638-2041 or (301) 443-6597, or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Omit be lyum

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Number(if known):

Device Name: Pancreatic Drainage Tube

Indications for Use:

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use	✓	Over-The-Counter Use
(Per 21 CFR 801.109)

	(Division Sign-Off)	(Optoinal Format 1-2-96)
	Division of Reproductive, Abdominal, and Radiological Devices
510(k) Number	K021672

Regulation Number and Section

§ 876.5010 Biliary catheter and accessories.

(a)
Identification. A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap.(b)
Classification. Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.